本文仅供中国大陆地区执业的医学药学专业人士参考，如您非前述专业人士，请离开本页面 本文仅供医疗卫生等专业人士参考审批码：TML0038594，有效期为 2025-01-21 至 2026-01-20，资料过期，视同作废内容策划：方程项目审核：于轩题图来源：图虫创意参考文献：[1]Fan Y, Zhou JY, Zhao Y, et al. Efficacy, safety, and ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.

Daily pill for lung cancer to be made routinely available on the NHS - According to Nice, osimertinib can help stop cancer ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Lung cancer disproportionately affects Black communities. Discover the causes, risk factors, and prevention strategies to ...

Liquid biopsy is an easy and non-invasive way to detect and treat lung cancer But is it as accurate as traditional biopsies ...

AstraZeneca has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for ...

Lung cancer expert Triparna Sen delivered a seminar in the Cancer Biology Seminar Series at the University of Wisconsin Jan.

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) ...

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.